tykhr
sign in
free sign up
XTL Biopharmaceuticals Ltd ADR
Biotechnology
Healthcare
XTLB
5.45 M shares
NASDAQ US
traded
12 Sep 2025
listed
no
open
1.44
52 week high
2.98
high
1.44
52 week low
0.00
low
1.35
growth
-48.67 %
previous Close
1.40
P/E ratio
market cap
11.63 M
div yield
0
usd
Mar 2025
qoq
revenue
289 K
0.00 %
net incoming
-255.00 K
0.00 %
eps
0.00 %
0.00 %
eps surprise
0.00 %
net profit margin
-88.24 %
0.00 %
operating incoming
-812.00 K
0.00 %
net change in cash
0.00 %
cash on hand
371 K
0.00 %
cost of revenue
332 K
0.00 %
top